Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Jefferies upgrades Reckitt Benckiser to 'hold'
(Sharecast News) - Jefferies upgraded Reckitt Benckiser to 'hold' from 'underperform' on Tuesday and lifted the price target to 4,400p from 4,100p. It noted the shares are down 23% year-to-date after a disappointing FY23 and "shock" US litigation risk.
Jefferies said the increased price target mostly reflects a reduced assumption on US litigation liability risk, related to NEC in premature babies and the alleged association of infant formula usage and negligent practices by some suppliers. NEC is a serious gastrointestinal problem that mostly affects premature infants.
"This is in part prompted by the formal stance taken by the NEC Society last week, which advises that recent litigation outcomes 'may result in unintended harmful consequences for babies & elimination of potentially beneficial therapy choices'," it said.
In the short term, Jefferies said it still considers some downside risk with 1Q24 sales. However, it said that at current levels, downside on the stock seems contained.
"Our 2026/27 estimates are cut (circa 3% at EPS) on an accelerated rebasing of margin expectation," it said. "We continue to see an op margin of 20-21% (versus 2023 23.1%) as more viable mid-term, if we are to see more consistent/sustained sales growth.
"Persistent uncertainties on strategy & litigation remain for the next 12 months. However, the skew to downside risk is more firmly established in the price. The company now has an opportunity to take control of some ambiguities, and set the investment case on an improved footing - so we move to hold."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.